Heart Rate Variability Drops 2 Days Before COVID-19 Symptoms in Female Soccer Players
Elite female soccer players showed significant HRV decreases 48 hours before testing positive for COVID-19, suggesting early detection potential.
Summary
Researchers tracked heart rate variability (HRV) in seven elite female soccer players for 30 days before they tested positive for COVID-19. Using smartphone photoplethysmography, they found significant drops in parasympathetic activity (LnRMSSD) starting 2 days before positive tests and continuing through the first 4 days of infection. The study suggests HRV monitoring could enable pre-symptomatic COVID-19 detection in athletes, potentially allowing earlier isolation and more informed return-to-play decisions based on autonomic nervous system recovery rather than just symptom resolution.
Detailed Summary
This study reveals that heart rate variability monitoring could serve as an early warning system for COVID-19 infection in elite athletes. Researchers from the University of Central Lancashire tracked seven elite female soccer players (age 20.14±6.41 years) using daily smartphone-based HRV measurements for at least 30 days before they tested positive for COVID-19.
The key finding was a significant decrease in LnRMSSD (natural log-transformed root mean square of successive differences), a marker of parasympathetic nervous system activity, beginning 2 days before positive PCR tests (p<0.01, Cohen's d=2.62). This decline continued through day -1 (Cohen's d=4.48) and persisted during the first 4 days of confirmed infection, with the largest effect on day 2 (Cohen's d=7.13). Resting heart rate also increased significantly during days 1-2 of infection.
The study used the validated HRV4Training smartphone app with photoplethysmography for 1-minute morning measurements. Six of seven players experienced moderate symptoms including fever, cough, and fatigue, while one had only mild symptoms. The 48-hour advance warning could enable pre-symptomatic isolation and contact tracing.
For athletes, this technology offers practical advantages over traditional symptom-based screening. The autonomic nervous system changes appear before clinical symptoms, potentially allowing teams to identify infected players earlier. Additionally, HRV monitoring could guide return-to-play decisions based on physiological recovery rather than just negative tests or symptom resolution, which is crucial given COVID-19's documented effects on cardiovascular and autonomic function.
Key Findings
- LnRMSSD decreased significantly 2 days before positive COVID-19 tests (p<0.01, Cohen's d=2.62)
- Parasympathetic activity remained suppressed for 4 consecutive days after positive tests (all p<0.01)
- Day 2 of infection showed the largest autonomic disruption (Cohen's d=7.13 for LnRMSSD)
- Resting heart rate increased significantly on days 1-2 of confirmed infection (p<0.05)
- 6 of 7 players experienced moderate symptoms while 1 had only mild symptoms
- RMSSD measurements were significantly lower during the first 4 days after positive tests
- Smartphone-based photoplethysmography successfully detected autonomic changes in field conditions
Methodology
Prospective observational study of 7 elite female soccer players tracked for ≥30 days before COVID-19 infection using validated HRV4Training smartphone app. Daily 1-minute morning HRV measurements via photoplethysmography in supine position. Statistical analysis used one-way ANOVA with Bonferroni post-hoc comparisons and Cohen's d effect sizes (p<0.05 significance).
Study Limitations
Very small sample size (n=7) limits generalizability. Study focused only on elite female soccer players, so findings may not apply to other populations or male athletes. Photoplethysmography is less precise than ECG gold standard. No control group of uninfected players for comparison during the same period.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.